ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Overview Fund Activity
Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

47 hedge funds and large institutions have $16.3M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 6 closing their positions.

Holders
47
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
10
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Mariner
1
Mariner
Kansas
$234K
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$445K
3
FA
3
Forefront Analytics
Pennsylvania
$61.2K
4
Jane Street
4
Jane Street
New York
$28.1K
5
Goldman Sachs
5
Goldman Sachs
New York
$7.5K

Top Sellers

1
DM
1
Deerfield Management
New York
$1.17M
2
BlackRock
2
BlackRock
New York
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$683K
4
UOC
4
UBS O'Connor
Illinois
$0
5
Verition Fund Management
5
Verition Fund Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
51
Simplex Trading
Illinois
– – -187 Closed
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$0 1 – –
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
Carson Wealth (CWM LLC)
54
Carson Wealth (CWM LLC)
Nebraska
$0 88 +88 New
1 2
3